Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1
CNS Oncology · 31.10.2015 · 4 (5) · 287-294
DOI: 10.2217/cns.15.32 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift CNS Oncology, online erschienen am 06.11.2015. Verfasst von Daniel P Cahill und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery & Translational Neuro-Oncology Laboratory, Harvard Medical School, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Chromosome Deletion. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Burroughs–Wellcome Career Award.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery & Translational Neuro-Oncology Laboratory, Harvard Medical School, Boston, MA 02115, USA.
- Massachusetts General Hospital Cancer Center, Harvard Medical School, 32 Fruit Street - Yawkey 9E, Boston, MA 02114, USA.
- Department of Pathology, Harvard Medical School, Boston, MA 02115, USA.
- Southern Alberta Cancer Research Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.
- Hotchkiss Brain Institute, University of Calgary, Calgary, AB T2N 1N4, Canada.
Förderung
- Burroughs–Wellcome Career Award
Zitieren
APA
Cahill, D. P., Louis, D. N., & Cairncross, J. G. (2015). Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1. CNS Oncology, 4(5), 287-294. https://doi.org/10.2217/cns.15.32
Vancouver
Cahill DP, Louis DN, Cairncross JG. Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1. CNS Oncology. 2015;4(5):287-294. doi:10.2217/cns.15.32
BibTeX
@article{Cahill2015,
author = {Cahill, Daniel P and Louis, David N and Cairncross, John Gregory},
title = {Molecular background of oligodendroglioma: 1p/19q, IDH, TERT, CIC and FUBP1},
journal = {CNS Oncology},
year = {2015},
volume = {4},
number = {5},
pages = {287--294},
doi = {10.2217/cns.15.32}
}
EUVIMED